PRESS: Norway contributes NOK 2 billion to IFFIm for COVID-19 vaccine

Lion's Head Global Partners are delighted to have supported CEPI (Coalition for Epidemic Preparedness Innovations) on the recent US$ 200m bond issuance to frontload the Kingdom of Norway's commitment towards CEPI's work on supporting COVID-19 vaccine candidates. Norway has committed NOK 2 billion (approximately US$ 200 million) to the International Finance Facility for Immunisation (IFFIm) to issue Vaccine Bonds that will expedite funding through Gavi, the Vaccine Alliance (Gavi) to CEPI, which is working to rapidly develop COVID-19 vaccine candidates. This follows on from a successful 2019 issuance, which was a unique transaction for Gavi/IFFIm in partnering with CEPI, and facilitating CEPI's rapid access to Norway's financial commitments to the organisation.

Written by
Published on